Deciphera Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Deciphera Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
  • Deciphera Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $3.76M, a 3.18% increase year-over-year.
  • Deciphera Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $16.6M, a 103% increase year-over-year.
  • Deciphera Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $16.4M, a 264% increase from 2022.
  • Deciphera Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $4.51M, a 3894% increase from 2021.
  • Deciphera Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $113K, a 97.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.4M +$11.9M +264% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-07
2022 $4.51M +$4.4M +3894% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-07
2021 $113K -$4.59M -97.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-07
2020 $4.7M -$3.77M -44.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-07
2019 $8.47M +$4.23M +99.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-08
2018 $4.25M +$3.59M +552% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-09
2017 $651K +$753K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 -$102K +$2.1M +95.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 -$2.21M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.